173290-17-0

Usage

Uses

Used in Organic Synthesis:
Methyl 3-iodopyrazine-2-carboxylate is used as a building block for the preparation of various pharmaceutical and agrochemical compounds. Its unique structure and functional groups make it a valuable intermediate in the synthesis of a wide range of organic compounds.
Used in Medicinal Chemistry:
Methyl 3-iodopyrazine-2-carboxylate is used as a key intermediate in the development of new pharmaceutical compounds. Its potential biological activities, such as antibacterial and antifungal properties, make it a promising candidate for the treatment of various diseases and infections.
Used in Agricultural Chemistry:
Methyl 3-iodopyrazine-2-carboxylate is used as a precursor in the synthesis of agrochemical compounds, such as pesticides and herbicides. Its versatility and reactivity in organic synthesis contribute to the development of effective and targeted agrochemicals for crop protection and management.

InChI:InChI=1/C6H5IN2O2/c1-11-6(10)4-5(7)9-3-2-8-4/h2-3H,1H3

Upstream product

• 16298-03-6 Methyl 3-amino-2-pyrazinecarboxylate 

Relevant academic research and scientific papers

ANTIDIABETIC SPIROCHROMAN COMPOUNDS

Novel compounds of the structural formula (I), and the pharmaceutically acceptable salts thereof, are agonists of G-protein coupled receptor 40 (GPR40) and may be useful in the treatment, prevention and suppression of diseases mediated by the G-protein-coupled receptor 40. The compounds of the present invention may be useful in the treatment of Type 2 diabetes mellitus, and of conditions that are often associated with this disease, including obesity and lipid disorders, such as mixed or diabetic dyslipidemia, hyperlipidemia, hypercholesterolemia, and hypertriglyceridemia.

NOVEL COMPOUND HAVING 4-PYRIDYLALKYLTHIO GROUP AS SUBSTITUENT

A subject of the present invention is to provide a novel aromatic five- or six-memberd heterocyclic derivative having 4-pyridylalkylthio as a substituent or a salt thereof which is useful as a pharmaceutical. Compound represented by the following general formula [I] or salts thereof are useful as therapeutic agents for diseases in which angiogenesis or augmentation of vascular permeability is involved. In the formula, ring "A" is a benzene ring or an aromatic five- or six-memberd heterocycle which can be fused with a cycloalkane ring, "B" is alkylene, R1 and R2, the same or different, are H, OH, substituted or unsubstituted alkoxy and the like, X and Y, the same or different, are group(s) selected from H, halogen, OH, substituted or unsubstituted alkoxy and the like respectively, p is 0, 1 or 2, and q is 0 or 1.